Stefan H Hohnloser Selected Research

celivarone

5/2012	Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
2/2012	Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions.
12/2011	Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan H Hohnloser Research Topics

Disease

149	Atrial Fibrillation 11/2022 - 06/2002
72	Stroke (Strokes) 08/2022 - 01/2003
62	Hemorrhage 08/2022 - 08/2005
32	Heart Failure 08/2022 - 06/2002
31	Embolism (Embolus) 08/2022 - 12/2010
19	Myocardial Infarction 01/2022 - 02/2003
14	Cardiac Arrhythmias (Arrythmia) 11/2022 - 10/2004
13	Atrial Flutter (Flutter, Atrial) 01/2022 - 06/2002
13	Ventricular Tachycardia 06/2017 - 07/2004
8	Shock 01/2019 - 06/2002
8	Cardiac Sudden Death (Sudden Cardiac Arrest) 06/2017 - 12/2003
8	Coronary Artery Disease (Coronary Atherosclerosis) 03/2017 - 01/2003
7	Hypertension (High Blood Pressure) 08/2022 - 01/2012
7	Chronic Renal Insufficiency 01/2022 - 10/2011
6	Heart Diseases (Heart Disease) 01/2022 - 06/2002
6	Tachycardia (Tachyarrhythmias) 01/2019 - 11/2002
6	Cardiomyopathies (Cardiomyopathy) 06/2017 - 03/2005
5	Ischemic Stroke 06/2019 - 12/2010
5	Sudden Death 06/2019 - 12/2011
5	Torsades de Pointes (Torsade de Pointes) 02/2012 - 04/2002
4	Left Ventricular Dysfunction 01/2022 - 01/2003
4	Thrombosis (Thrombus) 01/2019 - 11/2014
4	Ventricular Fibrillation 02/2015 - 01/2004
3	Diabetes Mellitus 08/2022 - 02/2017
3	Cardiac Tamponade 01/2021 - 01/2017
3	Acute Coronary Syndrome 01/2019 - 08/2011
3	Body Weight (Weight, Body) 01/2019 - 07/2004
3	Thromboembolism 04/2018 - 05/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 09/2008
3	Heart Arrest (Cardiac Arrest) 02/2012 - 12/2003
3	Long QT Syndrome 09/2010 - 04/2002
3	Infarction (Infarctions) 01/2006 - 08/2002
2	Hemorrhagic Stroke 04/2021 - 09/2011
2	Cerebral Hemorrhage 01/2021 - 11/2017
2	Infections 09/2020 - 06/2017
2	Inflammation (Inflammations) 01/2020 - 11/2011
2	Death (Near-Death Experience) 01/2018 - 02/2012
2	Hematoma 10/2017 - 01/2017
2	Bundle-Branch Block (Fascicular Block) 02/2017 - 01/2008
2	Coronary Disease (Coronary Heart Disease) 02/2014 - 12/2009
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2013 - 03/2011
2	Bradycardia 02/2009 - 01/2006
1	Vascular Diseases (Vascular Disease) 08/2022
1	ST Elevation Myocardial Infarction 08/2021

Drug/Important Bio-Agent (IBA)

52	Warfarin (Coumadin)FDA LinkGeneric 08/2022 - 09/2003
39	Dabigatran FDA Link 08/2022 - 12/2010
35	Vitamin K FDA Link 08/2022 - 05/2009
32	AnticoagulantsIBA 08/2022 - 09/2009
26	Dronedarone FDA Link 11/2022 - 08/2003
25	apixabanIBA 08/2022 - 03/2011
25	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 11/2007
21	Anti-Arrhythmia AgentsIBA 11/2022 - 06/2002
17	Clopidogrel (Plavix)FDA Link 08/2021 - 09/2003
14	RivaroxabanIBA 08/2022 - 05/2014
12	Pharmaceutical PreparationsIBA 01/2022 - 04/2002
10	TicagrelorIBA 08/2021 - 10/2017
9	Amiodarone (Amiodarona)FDA LinkGeneric 10/2016 - 06/2002
8	CreatinineIBA 01/2022 - 02/2009
6	N(4)-oleylcytosine arabinosideIBA 01/2021 - 03/2017
5	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 06/2017
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
5	Irbesartan FDA LinkGeneric 03/2015 - 09/2003
4	Phenprocoumon (Liquamar)FDA Link 06/2019 - 02/2012
4	Factor Xa InhibitorsIBA 01/2019 - 09/2011
4	Digoxin (Digitek)FDA LinkGeneric 01/2018 - 08/2014
4	azimilideIBA 09/2008 - 12/2004
3	DiureticsIBA 01/2022 - 11/2009
3	edoxabanIBA 01/2021 - 04/2018
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2020 - 09/2009
3	Thrombin FDA Link 01/2020 - 12/2010
3	Cystatin CIBA 01/2020 - 11/2012
3	celivaroneIBA 05/2012 - 12/2011
2	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 12/2021 - 10/2017
2	C-Reactive ProteinIBA 01/2020 - 11/2011
2	Ion Channels (Ion Channel)IBA 08/2019 - 08/2008
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2014 - 04/2012
2	Troponin IIBA 08/2014 - 04/2012
2	pro-brain natriuretic peptide (1-76)IBA 08/2014 - 04/2012
2	Proteins (Proteins, Gene)FDA Link 01/2011 - 08/2008
2	Adenosine Triphosphate (ATP)IBA 12/2004 - 11/2002
1	Factor Xa (Coagulation Factor Xa)IBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Verapamil (Calan)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2020
1	Proton Pump InhibitorsIBA 07/2020
1	Prothrombin (Factor II)IBA 01/2020

Therapy/Procedure

88	Therapeutics 01/2022 - 06/2002
30	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 09/2020 - 11/2002
23	Defibrillators (Defibrillator) 06/2019 - 11/2002
18	Catheter Ablation 03/2020 - 08/2002
17	Percutaneous Coronary Intervention 01/2022 - 10/2016
16	Electric Countershock (Cardioversion) 10/2021 - 06/2002
7	Secondary Prevention 09/2020 - 06/2005
7	Cardiac Resynchronization Therapy 10/2019 - 06/2002
3	Drug Therapy (Chemotherapy) 03/2017 - 06/2002
2	Drug Tapering 04/2018 - 01/2016
2	Stents 01/2018 - 10/2016
1	Contraindications 01/2021
1	Punctures 01/2021
1	Device Removal (Removal, Device) 09/2020